Actualités 58067
BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor
Fri, 13 Dec 2024 03:09:00 GMT
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced it has entered into a global licensing agreem ...